What to Know Before Signing With an MCO

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 7
Volume 17
Issue 7

For some oncology practices, it makes sense to contract with a managed care organization (MCO)-a contract simply enables you to treat enrollees of an MCO.

ABSTRACT: Pay special attention to provisions that spell out the services to be furnished, the payment amounts, and the terms of payment.

For some oncology practices, it makes sense to contract with a managed care organization (MCO)-a contract simply enables you to treat enrollees of an MCO.

Typically, the payment method under a managed care contract for oncology services is discounted charges, with the amount of the discount negotiated between the practice and the MCO.

However, such contracts are complicated and need to be reviewed carefully. Pay special attention to provisions that spell out the services to be furnished, the payment amounts, and the terms of payment.

It is also important to have a complete understanding of the MCO’s payment for each CPT code.

Five Important Questions to Ask

1. How important is this contract to your practice? The answer determines what the contract means in terms of your revenue and expenses, and leads to another question: What are your alternatives to this contract?

2. How does the contract define “medically necessary” care? It is vital to understand if the contract uses an objective standard, such as a “prudent physician” standard, or if it gives the MCO wide flexibility in determining what is medically necessary treatment.

3. Does the MCO have an obligation to pay you promptly? Make sure that the contract includes a specific payment period, and the MCO should agree to pay interest if it delays payment beyond the agreed-to period. Many states have laws requiring prompt payment.

4. Can the MCO change reimbursement terms unilaterally? If so, make sure that the MCO is required to provide you notice of any such reimbursement changes.

5. How can you terminate the contract? Make sure there is adequate room for terminating the contract if, for instance, the MCO breaches its agreement in any way. Also, ask whether the MCO is obligated to provide notice of your rights to terminate every year.

Recent Videos
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Related Content